UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039036
Receipt number R000044516
Scientific Title Factors influencing gait velocity improvement following botulinum toxin injection for plantar flexors spasticity in patients with stroke
Date of disclosure of the study information 2019/12/31
Last modified on 2020/09/28 09:28:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Factors influencing gait velocity improvement following botulinum toxin injection for plantar flexors spasticity in patients with stroke

Acronym

Factors influencing gait improvement after botulinum therapy

Scientific Title

Factors influencing gait velocity improvement following botulinum toxin injection for plantar flexors spasticity in patients with stroke

Scientific Title:Acronym

Factors influencing gait improvement after botulinum therapy

Region

Japan


Condition

Condition

stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to clarify the factors affecting gait velocity improvement after
botulinum toxin type A injection.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

gait velocity, spasticity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Non-randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment Behavior,custom Maneuver

Interventions/Control_1

BoNT-A administration: 300 units

Interventions/Control_2

BoNT-A administration: 300 units
Physical therapy: 2 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1.Unilateral lesions in the cerebrum; 2. At least 6 months since stroke onset; 3. Walking ability at monitoring level or higher; 4.Spasticity of at least 1+ on the modified Ashworth scale in the ankle plantar flexor muscle.

Key exclusion criteria

1. Higher brain dysfunction that presents problems for intervention and/or evaluation; 2. Cardiovascular disease that restricts exercise; 3. BoNT-A administration within the previous 4 months.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Kazuki
Middle name
Last name Fujita

Organization

Fukui Health Science University

Division name

Faculty of Health Science, Department of Rehabilitation

Zip code

910-3190

Address

Egami 55-13-1, Fukuishi, Fukui, 910-3190, Japan

TEL

0776-59-2200

Email

k.fujita@fukui-hsu.ac.jp


Public contact

Name of contact person

1st name Kazuki
Middle name
Last name Fujita

Organization

Fukui Health Science University

Division name

Faculty of Health Science, Department of Rehabilitation

Zip code

910-3190

Address

Egami 55-13-1, Fukuishi, Fukui, 910-3190, Japan

TEL

0776-59-2200

Homepage URL


Email

k.fujita@fukui-hsu.ac.jp


Sponsor or person

Institute

Fukui Health Science University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nittazuka Medical Welfare Center

Address

Egami 58-16-1, Fukuishi, Fukui, 910-3190, Japan

Tel

0776-59-1300

Email

fgh-hisyo@mopera.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

60

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 08 Month 09 Day

Date of IRB

2014 Year 04 Month 16 Day

Anticipated trial start date

2014 Year 09 Month 01 Day

Last follow-up date

2019 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 12 Month 31 Day

Last modified on

2020 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044516


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name